drugset / Trial / NCT00855959
Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of the study is to show similarity of efficacy on Pulmicort Respules 1.0 mg/day or 2.0 mg/day for 6 weeks in the treatment period and the corresponding doses of Pulmicort Turbuhaler 400 μg/day or 800 μg/day for 4 weeks in the observation period in Japanese adult asthmatic patients with age of 16 years or older.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 200 ug | Inhaled |
| Subject | Budesonide | Small molecule | 400 ug | Inhaled |
| Subject | Budesonide | Small molecule | 0.5 mg | Inhaled |
| Subject | Budesonide | Small molecule | 1 mg | Inhaled |